Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Leuprolide Mesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 481,503Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Leuprorelin mesilate, Leuprorelin mesylate, Camcevi, 8e3c3c493w, Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 mesylate, Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 methanesulfonate
    Molecular Formula
    C60H88N16O15S
    Molecular Weight
    1305.5  g/mol
    InChI Key
    MBIDSOMXPLCOHS-XNHQSDQCSA-N
    FDA UNII
    8E3C3C493W
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;methanesulfonic acid
    2.1.2 InChI
    InChI=1S/C59H84N16O12.CH4O3S/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40;1-5(2,3)4/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64);1H3,(H,2,3,4)/t40-,41-,42-,43+,44-,45-,46-,47-,48-;/m0./s1
    2.1.3 InChI Key
    MBIDSOMXPLCOHS-XNHQSDQCSA-N
    2.1.4 Canonical SMILES
    CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CS(=O)(=O)O
    2.1.5 Isomeric SMILES
    CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6.CS(=O)(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    8E3C3C493W
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Leuprorelin Mesilate

    2. Leuprorelin Mesylate

    3. Camcevi

    4. 8e3c3c493w

    5. Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 Mesylate

    6. Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 Methanesulfonate

    7. 1-9-luteinizing Hormone-releasing Factor (swine), 6-d-leucine-9-(n-ethyl-l-prolinamide)-, Methanesulfonate (1:1)

    8. 944347-41-5

    9. Unii-8e3c3c493w

    10. Schembl4075500

    11. Chembl4802223

    12. Leuprorelin Mesilate [who-dd]

    13. Leuprolide Mesylate [orange Book]

    14. Q27270242

    2.4 Create Date
    2014-05-03
    3 Chemical and Physical Properties
    Molecular Weight 1305.5 g/mol
    Molecular Formula C60H88N16O15S
    Hydrogen Bond Donor Count16
    Hydrogen Bond Acceptor Count17
    Rotatable Bond Count32
    Exact Mass1304.63357734 g/mol
    Monoisotopic Mass1304.63357734 g/mol
    Topological Polar Surface Area494 Ų
    Heavy Atom Count92
    Formal Charge0
    Complexity2480
    Isotope Atom Count0
    Defined Atom Stereocenter Count9
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Indication

    Camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.